1. Phase I trial of recombinant human g-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer;Abbruzzese;Cancer Res.,1989
2. Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor;Agah;J. biol. Resp. Modif.,1988
3. Successful therapy of natural killer-resistant pulmonary metastases by the synergism of g-interferon with tumor necrosis factor and interleukin-2 in mice;Agah;Cancer Res.,1988
4. Synergistic enhancement by tumor necrosis factor of in vivo cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II;Alexander;Cancer Res.,1987
5. Interferon-g for the treatment of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responses;Aulitzky;Immunobiology,1987